Patent ID: 11953506
Assignee: MOLOGIC LIMITED
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 3:
4. The method according to claim 1, further comprising determining levels of at least one further marker in the urine samples, wherein the at least one further marker is selected from myeloperoxidase (MPO), large elastin fragments (LEF), cystatin C, alpha-1 antitrypsin (A1AT), ICAM-1, IL-6, IL-1β, IL-8, N-formyl-Met-Leu-Phe (fMLP), IL-6 induced fibrinogen, cytokine induced beta-2-microglobulin (B2M), retinol binding protein 4 (RBP4), calprotectin; a protease activity selected from matrix metalloproteinase (MMP) activity, human neutrophil elastase (HNE) activity or cathepsin G activity; N-acetyl Pro-Gly-Pro (Ac-PGP), desmosine, human serum albumin (HSA), chlorinated peptides, lactic acid, free fatty acids, an extracellular matrix breakdown product or elastin fragments/peptides.